✨ Join a Leading Hem/Onc Team: Exceptional Career Opportunities Across North Central Florida

HIGHLIGHTS

Discover an exceptional Hematology/Oncology opportunity with Florida Cancer Specialists & Research Institute in beautiful North Central Florida, a region known for its welcoming communities, outstanding schools, and attractive real estate options ideal for both growing families and established professionals.

POSITION OVERVIEW

• The practice is seeking a team-oriented fellowship-trained general hematologist/oncologist.
• This is an excellent full-time opportunity to join a dynamic team committed to delivering superior, patient, and community-centered care.
• Candidates’ responsibilities include outpatient clinics, clinical research, chemotherapy supervision, inpatient, and consultation services.
• Candidates’ responsibilities will include managing both malignant cancers and benign hematological diagnoses.
• The physician would have the opportunity to participate in research and clinical trials.

BENEFITS

• No FL state income tax
• Competitive salary, relocation assistance, and CME reimbursement
• Partnership track
• PTO, malpractice, medical benefits, 401k
• Positive impact on the community

REQUIREMENTS

• Full unrestricted Florida MD/DO License
• BC/BE in Hematology/Oncology
• Rotating rounding/call is required.
  
• Fellows welcome

About FCS

Since 1984, Florida Cancer Specialists & Research Institute (FCS) has built a national reputation for excellence. With over 250 physicians, 220 nurse practitioners and physician assistants, and nearly 100 locations in our network. Utilizing innovative clinical research, cutting-edge technologies, and advanced treatments, we are committed to providing world-class cancer care. We are recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award. FCS offers patients access to more clinical trials than any private oncology practice in Florida. Our patients have access to groundbreaking therapies in a community setting and may participate in national clinical research studies on drugs and treatment protocols. In the past five years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with FCS participation prior to approval.

Through our partnership with Sarah Cannon, we are one of the largest clinical research organizations in the United States. Often, FCS leads the nation in initiating research studies and offering ground-breaking new therapies to patients.